Uristat launch brings J&J into OTC urinary pain analgesic market.
This article was originally published in The Tan Sheet
Executive Summary
J&J ENTERS OTC URINARY TRACT PAIN RELIEF CATEGORY with the marketing launch of Uristat during the week of June 18. Marketed by J&J's Advanced Care Products, the phenazopyridine hydrochloride 95 mg analgesic is indicated for the temporary relief of pain and discomfort associated with urinary tract infections. Uristat "relieves the pain but is not a cure," J&J said, stressing that "only a doctor can treat a UTI."